Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00XIB
|
|||
Former ID |
DNC005130
|
|||
Drug Name |
1-acetamido-5-sulfonamidoindane
|
|||
Synonyms |
N-(5-Sulfamoyl-indan-1-yl)-acetamide
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H14N2O3S
|
|||
Canonical SMILES |
CC(=O)NC1CCC2=C1C=CC(=C2)S(=O)(=O)N
|
|||
InChI |
1S/C11H14N2O3S/c1-7(14)13-11-5-2-8-6-9(17(12,15)16)3-4-10(8)11/h3-4,6,11H,2,5H2,1H3,(H,13,14)(H2,12,15,16)
|
|||
InChIKey |
RUUYVLNZHGCPRP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9. | |||
REF 2 | Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.